BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Long-term Debt
Borrowings due after more than one year.
BillionToOne, Inc.NASDAQ: BLLN
Long-term Debt · Q2 FY2026 · quarter ended Jun 2026
Long-term debt rises 74.8% from a year ago
Long-term debt stood at $91.03M at the end of Q2 FY2026, up 74.8% from a year earlier and up 1.1% from the prior quarter.
Context
- Long-term debt amounted to 12.5% of total assets at the end of Q2 FY2026, down 4.2 pp from a year earlier.
- Long-term debt increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether long-term debt keeps rising in the next quarterly balance sheet after a +74.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 57.23M USD
- Year-over-year change
- +11.2%
- 2-year CAGR
- +27.9%
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 57.23M | +11.2% |
| FY2024 | 2024-12-31 | 51.48M | +47.1% |
| FY2023 | 2023-12-31 | 35M | — |
Long-term Debt vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 long-term debt of $91.03M is the 5th highest of the 9 companies compared; the peer median is $49.16M.
- Its year-over-year change of +74.8% is the 3rd highest of 6, against a peer median of +34.8%.
- Long-term debt amounts to 12.5% of total assets for BLLN, versus a peer median of 10.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $1.5B | +34.8% | +9.8% | 79.7% | |
| Jun 2026 | $374.24M | +9.7% | -8.9% | 27.7% | |
| Mar 2026 | $204.4M | +244.7% | +15.7% | 30.3% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $96.84M | +87.4% | +140.5% | 20.1% |
BLLNBillionToOne, Inc. | Jun 2026 | $91.03M | +74.8% | — | 12.5% |
| Mar 2026 | $1.48M | -24.6% | -16.6% | 0.1% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BLLN) | $49.16M | +34.8% | +9.8% | 10.1% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.